AMICULUM's agencies have supported clients with healthcare communications assignments related to new treatments for rare diseases for over 12 years.
We have now launched Comradis, an agency dedicated to the provision of support for the development of, and promotion of access to, effective treatments for rare diseases.
Comradis provides support in three key areas:
- Communications relating to rare diseases
- Communities for rare disease stakeholders (professional and lay groups)
- Commercialization strategies for new treatments
The Comradis team comprises experienced AMICULUM agency personnel based in East Asia, the UK and USA.
For further information on the support available from Comradis, please contact our team